Previous close | 0.1500 |
Open | 2.4600 |
Bid | 0.0000 |
Ask | 2.3500 |
Strike | 20.00 |
Expiry date | 2024-06-21 |
Day's range | 1.2300 - 2.4600 |
Contract range | N/A |
Volume | |
Open interest | 30 |
We have narrowed our search to five small-cap biotech stocks with strong potential for the rest of 2024. These are: ARQT, BCYC, CSTL, PRME, LXRX.
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
CAMBRIDGE, England & BOSTON, June 03, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in June: